Fig. 1: Individual plasma concentration–time curves for patients treated with 60 mg/m² (recommended phase 2 dose).

Infusion times were in the range of 115–346 min. For the sake of simplicity, the infusion time has been arbitrarily shortened and presented uniformly for all patients.